Pure Global AI
NCT06356363Not yet recruiting

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway
Institut Jean-GodinotClinicalTrials.govother
Study focus
Disease/Condition
Cancer
Drug/Device/Intervention
Data collection
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Institut Jean-Godinot
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2024
End date
Nov 01, 2025
Enrollment
500 participants
Primary outcome

Psychometric validation

Summary

Healthcare systems are evolving, giving increasing prominence to the patient-centered model,
 accompanied by objective and perceived outcomes.
 
 PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their
 experience of care. PREMs enable patients to take an active role in their own care, and
 enable healthcare establishments to identify areas for improvement that can be incorporated
 into their quality processes.
 
 In oncology, the collection of patient-perceived quality regarding their care pathway would
 enable better coordination of their care. While a few initiatives have emerged in the field
 of PREMs, the development of a reliable questionnaire assessing patient perception of their
 care pathway in oncology remains a challenge.

ICD-10 classifications
Carcinoid syndromeOther chemotherapyCarcinoma in situ, unspecifiedMalignant neoplasmsMalignant neoplasm: Prepuce
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06356363
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06356363 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut Jean-Godinot and is currently Not yet recruiting. The study focuses on Cancer. Target enrollment is 500 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.